CIRM Awards $1.3 Million to Greenstone Bio for Innovative Cardiovascular Stem Cell Research

Greenstone Biosciences, Inc., a commercial-stage computational biology company, announces that the company has received a DISC0 grant funding from the California Institute of Regenerative Medicine (CIRM).